Mary Lynch MD, FRCPC
Affiliated with the Dalhousie University Pain Research Group
Dr. Mary Lynch is Professor of Psychiatry, Anesthesia and Pharmacology at Dalhousie University. She is Director of the Pain Management Unit, Queen Elizabeth II Health Sciences Centre and Capital District Health Authority, Halifax, Nova Scotia. Dr. Lynch has 18 years of experience as a clinician assisting patients with chronic pain. She is the author of the self-help manual “Surviving Your Personal Injuries Claim and Litigation”. Dr Lynch chaired the Canadian Pain Society Wait Times Task Force and serves as President elect of the Canadian Pain Society. Her research interests have focused on the development of new agents for the treatment of neuropathic pain. She is Principal investigator of the Canadian Foundation for Innovation funded Canadian Pain Trials Network, founding Director of the Canadian Consortium for the Investigation of Cannabinoids and was awarded a Mayday Fellowship for 2007-2008.
Lynch ME, Campbell F, Clark AJ, Goldstein D, Dunbar M, Peng P, Stinson J, Tupper H, A systematic review of the effect of waiting for treatment for chronic pain Pain 2007 Aug 16; Epub ahead of printPMID 17707589
Lynch ME, Campbell F, Clark AJ, Goldstein D, Dunbar M, Peng P, Stinson J, Tupper H, Waiting for treatment for chronic pain; a survey of existing benchmarks:Towards establishing evidence based benchmarks for medically acceptable waiting times Pain Res Manage, WInter 2007)
Lynch ME, Watson CPW. The pharmacotherapy of chronic pain, a review. Pain Res Manage,2006; 11: 11-38.
Lynch ME, Young J, Clark AJ, A case series of patients using medicinal marihuana for chronic pain under the Canadian marihuana medical access regulations, J Pain Symptom Manage ,2006;32:497-501.
Lynch ME, Clark AJ, Sawynok J, Sullivan M. Topical amitriptyline and ketamine in neuropathic pain syndromes, an open label trial J Pain, 2005;6:644-649.
Lynch, ME, A review of the use of methadone for treatment of chronic non cancer pain. Pain Res Manage, 2005;10:133-144.
Lynch ME, Pre-clinical science regarding cannabinoids as analgesics: an overview. Pain Res Manage, 2005;10:7A-14A.
Lynch ME, Clark AJ, Sawynok J, Sullivan M. Topical amitriptyline 2% and ketamine 1% in neuropathic pain syndromes: a randomized double blind placebo controlled trial. Anesthesiology, 2005;103: 140-146.
Information last updated 2009-06-22.